On the public citation graph
Expression of PD-L1 and presence of CD8-positive T cells in pre-treatment specimens of locally advanced cervical cancer
0 signed · 230 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1001/jamaoncol.2015.3638openalex-snapshot
Quantitative Assessment of the Heterogeneity of PD-L1 Expression in Non–Small-Cell Lung Cancer
inferredcites →https://doi.org/10.1001/jamaoncol.2015.6326openalex-snapshot
Genetic Basis for PD-L1 Expression in Squamous Cell Carcinomas of the Cervix and Vulva
inferredcites →https://doi.org/10.1002/ijc.29210openalex-snapshot
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
inferredcites →https://doi.org/10.1007/s12105-012-0406-zopenalex-snapshot
B7-H1 Expression Model for Immune Evasion in Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma
inferredcites →https://doi.org/10.1007/s12307-011-0066-7openalex-snapshot
Immunosuppressive Tumor Microenvironment in Cervical Cancer Patients
inferredcites →https://doi.org/10.1016/j.ejca.2015.11.020openalex-snapshot
Predictive relevance of PD-L1 expression combined with CD8+ TIL density in stage III non-small cell lung cancer patients receiving concurrent chemoradiotherapy
inferredcites →https://doi.org/10.1016/j.ejca.2016.03.002openalex-snapshot
High levels of the soluble programmed death-ligand (sPD-L1) identify hepatocellular carcinoma patients with a poor prognosis
inferredcites →https://doi.org/10.1016/j.ijrobp.2012.06.021openalex-snapshot
The Significance of Tumoral ERCC1 Status in Patients With Locally Advanced Cervical Cancer Treated With Chemoradiation Therapy: A Multicenter Clinicopathologic Analysis
inferredcites →https://doi.org/10.1016/j.jtho.2016.01.015openalex-snapshot
The Role of Tumor-Infiltrating Lymphocytes in Development, Progression, and Prognosis of Non–Small Cell Lung Cancer
inferredcites →https://doi.org/10.1016/j.ygyno.2013.11.015openalex-snapshot
PIK3CA missense mutation is associated with unfavorable outcome in grade 3 endometrioid carcinoma but not in serous endometrial carcinoma
inferredcites →https://doi.org/10.1016/s0140-6736(15)01281-7openalex-snapshot
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
inferredcites →https://doi.org/10.1016/s0140-6736(16)00561-4openalex-snapshot
Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial
inferredcites →https://doi.org/10.1016/s0140-6736(16)00587-0openalex-snapshot
Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial
inferredcites →https://doi.org/10.1016/s1470-2045(16)30066-3openalex-snapshot
Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial
inferredcites →https://doi.org/10.1038/modpathol.2015.108openalex-snapshot
Enhanced expression of PD L1 in cervical intraepithelial neoplasia and cervical cancers
inferredcites →https://doi.org/10.1038/modpathol.2016.64openalex-snapshot
Prognostic effect of different PD-L1 expression patterns in squamous cell carcinoma and adenocarcinoma of the cervix
inferredcites →https://doi.org/10.1038/nature12477openalex-snapshot
Signatures of mutational processes in human cancer
inferredcites →https://doi.org/10.1038/nature13904openalex-snapshot
MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
inferredcites →https://doi.org/10.1038/nature14011openalex-snapshot
Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
inferredcites →https://doi.org/10.1056/nejmoa1200694openalex-snapshot
Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
inferredcites →https://doi.org/10.1056/nejmoa1504030openalex-snapshot
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
inferredcites →https://doi.org/10.1056/nejmoa1602252openalex-snapshot
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
inferredcites →https://doi.org/10.1097/pai.0000000000000256openalex-snapshot
Development of an Automated PD-L1 Immunohistochemistry (IHC) Assay for Non–Small Cell Lung Cancer
inferredcites →https://doi.org/10.1126/scitranslmed.aad7118openalex-snapshot
PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
inferredcites →https://doi.org/10.1158/0008-5472.can-12-2384openalex-snapshot
Evidence for a Role of the PD-1:PD-L1 Pathway in Immune Resistance of HPV-Associated Head and Neck Squamous Cell Carcinoma
inferredcites →https://doi.org/10.1158/1078-0432.ccr-09-1652openalex-snapshot
Tumor-Expressed B7-H1 and B7-DC in Relation to PD-1+ T-Cell Infiltration and Survival of Patients with Cervical Carcinoma
inferredcites →https://doi.org/10.1158/1078-0432.ccr-15-2042openalex-snapshot
The Immune Checkpoint Regulator PD-L1 Is Highly Expressed in Aggressive Primary Prostate Cancer
inferredcites →https://doi.org/10.1158/1535-7163.mct-14-0983openalex-snapshot
PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy
inferredcites →https://doi.org/10.1158/2326-6066.cir-14-0133openalex-snapshot
PD-L1 Expression Correlates with Tumor-Infiltrating Lymphocytes and Response to Neoadjuvant Chemotherapy in Breast Cancer
inferredcites →https://doi.org/10.1159/000453569openalex-snapshot
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
inferredcites →https://doi.org/10.1159/000455014openalex-snapshot
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
inferredcites →https://doi.org/10.1186/s13058-015-0575-2openalex-snapshot
Low ATM protein expression in malignant tumor as well as cancer-associated stroma are independent prognostic factors in a retrospective study of early-stage hormone-negative breast cancer
inferredcites →https://doi.org/10.1186/s40425-015-0059-zopenalex-snapshot
The therapeutic promise of disrupting the PD-1/PD-L1 immune checkpoint in cancer: unleashing the CD8 T cell mediated anti-tumor activity results in significant, unprecedented clinical efficacy in various solid tumors
inferredcites →https://doi.org/10.1200/jco.2008.16.4368openalex-snapshot
Reducing Uncertainties About the Effects of Chemoradiotherapy for Cervical Cancer: A Systematic Review and Meta-Analysis of Individual Patient Data From 18 Randomized Trials
inferredcites →https://doi.org/10.1530/erc-12-0313openalex-snapshot
Differentiated thyroid carcinomas may elude the immune system by B7H1 upregulation
inferredcites →https://doi.org/10.18632/oncotarget.3216openalex-snapshot
Prognostic and predictive value of PDL1 expression in breast cancer
inferredcites →https://doi.org/10.2307/2529310openalex-snapshot
The Measurement of Observer Agreement for Categorical Data
inferredcites →https://doi.org/10.2307/2532051openalex-snapshot
A Concordance Correlation Coefficient to Evaluate Reproducibility
inferredcites →https://doi.org/10.3390/ijms17071046openalex-snapshot
PD-L1 Immunohistochemical Detection in Tumor Cells and Tumor Microenvironment: Main Considerations on the Use of Tissue Micro Arrays
inferredcites →https://doi.org/10.3892/or.2015.4435openalex-snapshot
Relationship between expression of PD-L1 and PD-L2 on esophageal squamous cell carcinoma and the antitumor effects of CD8+ T cells
inferredcites →https://doi.org/10.4137/cmo.s34540openalex-snapshot
Tumor-Infiltrating Lymphocytes in Triple Negative Breast Cancer: The Future of Immune Targeting
inferredcites →https://doi.org/10.5306/wjco.v5.i2.86openalex-snapshot
Different strategies of treatment for uterine cervical carcinoma stage IB2-IIB
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.5044981openalex-extracted
Efficacy and Safety of Immune Checkpoint Inhibitors Combined with TKIs for Recurrent or Metastatic Cervical Cancer with PIK3CA Mutation: A Secondary Analysis Based on Two Prospective Studies
inferred← citeshttps://doi.org/10.1001/jamaoncol.2017.3776openalex-snapshot
Association of Ipilimumab With Safety and Antitumor Activity in Women With Metastatic or Recurrent Human Papillomavirus–Related Cervical Carcinoma
inferred← citeshttps://doi.org/10.1002/advs.202203040openalex-snapshot
Single‐Nucleus RNA Sequencing and Spatial Transcriptomics Reveal the Immunological Microenvironment of Cervical Squamous Cell Carcinoma
inferred← citeshttps://doi.org/10.1002/cam4.5826openalex-snapshot
Anti‐tumor effects of miR ‐34a by regulating immune cells in the tumor microenvironment
inferred← citeshttps://doi.org/10.1002/cbf.4010openalex-snapshot
Adenosine increases PD‐L1 expression in mesenchymal stromal cells derived from cervical cancer through its interaction with A2AR/A2BR and the production of TGF‐β1
inferred← citeshttps://doi.org/10.1002/cnr2.2057openalex-snapshot
Comparison of programmed death‐ligand 1 expression in adenocarcinoma and squamous cell carcinoma of the cervix in paraffin blocks of patients with cervical cancer
inferred← citeshttps://doi.org/10.1002/iid3.70464openalex-snapshot
Expression of Programmed Death‐Ligand 1 in Cervical Cancer: Correlation With Histologic Subtypes and Clinicopathological Features
inferred← citeshttps://doi.org/10.1002/ijc.32893openalex-snapshot
Immunologic impact of chemoradiation in cervical cancer and how immune cell infiltration could lead toward personalized treatment
inferred← citeshttps://doi.org/10.1002/ijgo.70280openalex-snapshot
Immune checkpoint inhibitors in gynecologic oncology: Current status and perspectives
inferred← citeshttps://doi.org/10.1002/ijgo.70648openalex-snapshot
Immune checkpoint therapy in locally advanced, persistent, recurrent, and metastatic cervical cancer: A systematic review and Bayesian network meta‐analysis
inferred← citeshttps://doi.org/10.1002/jcb.29447openalex-snapshot
LINC00116 enhances cervical cancer tumorigenesis through miR‐106a/c‐Jun pathway
inferred← citeshttps://doi.org/10.1002/jmv.28717openalex-snapshot
Infection pattern and immunological characteristics of Epstein‐Barr virus latent infection in cervical squamous cell carcinoma
inferred← citeshttps://doi.org/10.1007/16833_2023_161openalex-snapshot
Tumor-Infiltrating Lymphocytes (TILs) and Gynecological Cancers
inferred← citeshttps://doi.org/10.1007/978-981-15-3266-5_8openalex-snapshot
Spatiotemporal Changes in Checkpoint Molecule Expression
inferred← citeshttps://doi.org/10.1007/978-981-99-9396-3_15openalex-snapshot
New Therapeutic Strategies for Cervical Cancer with Special Reference to Immunotherapy
inferred← citeshttps://doi.org/10.1007/978-981-99-9396-3_16openalex-snapshot
Molecular Target Drug for Cervical Cancer
inferred← citeshttps://doi.org/10.1007/s00066-019-01571-1openalex-snapshot
Association between radiotherapy-induced alteration of programmed death ligand 1 and survival in patients with uterine cervical cancer undergoing preoperative radiotherapy
inferred← citeshttps://doi.org/10.1007/s00129-019-4457-zopenalex-snapshot
Innovative Therapien beim metastasierten Zervixkarzinom
inferred← citeshttps://doi.org/10.1007/s00262-024-03823-1openalex-snapshot
Toripalimab combined with definitive chemoradiotherapy for locally advanced cervical squamous cell carcinoma patients (TRACE): A single-arm, phase I/II trial
inferred← citeshttps://doi.org/10.1007/s00428-020-02922-5openalex-snapshot
PD-L1 expression is associated with tumor infiltrating lymphocytes that predict response to NACT in squamous cell cervical cancer
inferred← citeshttps://doi.org/10.1007/s11684-018-0674-4openalex-snapshot
PD-1/PD-L1 blockade in cervical cancer: current studies and perspectives
inferred← citeshttps://doi.org/10.1007/s11912-018-0740-8openalex-snapshot
Combination Immune Checkpoint Blockade Strategies to Maximize Immune Response in Gynecological Cancers
inferred← citeshttps://doi.org/10.1007/s12094-025-03852-xopenalex-snapshot
Evaluating the benefits of immunotherapy in metastatic cervical cancer: an observational retrospective analysis
inferred← citeshttps://doi.org/10.1007/s15004-021-8694-7openalex-snapshot
Immuntherapien - Hoffnungsträger in der Therapie des Zervixkarzinoms
inferred← citeshttps://doi.org/10.1007/s40199-026-00660-8openalex-snapshot
Therapy resistance-related ncRNAs in cervical cancer: biomarkers and therapeutic targets
inferred← citeshttps://doi.org/10.1007/s40291-022-00576-4openalex-snapshot
Prognostic Value of Programmed Death Ligand-1 Expression in Solid Tumors Irrespective of Immunotherapy Exposure: A Systematic Review and Meta-Analysis
inferred← citeshttps://doi.org/10.1007/s40944-021-00584-yopenalex-snapshot
Programmed Death Ligand 1 (PD-L1) Expression in Cervical Cancer
inferred← citeshttps://doi.org/10.1007/s40944-026-01101-9openalex-snapshot
Determining Pdl1 Receptors Expression in Cervical Squamous Carcinoma with Various Clinico-Etio-Pathological Correlation
inferred← citeshttps://doi.org/10.1007/s43032-022-00851-zopenalex-snapshot
Constructing a Novel Signature Based on Immune-Related lncRNA to Improve Prognosis Prediction of Cervical Squamous Cell Carcinoma Patients
inferred← citeshttps://doi.org/10.1016/b978-0-443-28985-9.00005-7openalex-snapshot
Current treatment options and limitations for cervical cancer
inferred← citeshttps://doi.org/10.1016/j.adcanc.2022.100074openalex-snapshot
Insights into therapy resistance in cervical cancer
inferred← citeshttps://doi.org/10.1016/j.biopha.2023.115355openalex-snapshot
Manipulating TGF-β signaling to optimize immunotherapy for cervical cancer
inferred← citeshttps://doi.org/10.1016/j.brachy.2019.09.009openalex-snapshot
Changes of CD68, CD163, and PD-L1 tumor expression during high-dose-rate and pulsed-dose-rate brachytherapy for cervical cancer
inferred← citeshttps://doi.org/10.1016/j.canrad.2024.09.006openalex-snapshot
Personalized strategies for brachytherapy of cervix cancer
inferred← citeshttps://doi.org/10.1016/j.clinthera.2026.03.007openalex-snapshot
Rechallenging Immunotherapy With Cadonilimab (PD-1/CTLA-4 Bispecific Antibody) Achieved Partial Response in a Heavily Treated Patient With Metastatic Cervical Cancer: Case Report
inferred← citeshttps://doi.org/10.1016/j.clon.2019.07.003openalex-snapshot
The Role of Biomarkers for the Prediction of Response to Checkpoint Immunotherapy and the Rationale for the Use of Checkpoint Immunotherapy in Cervical Cancer
inferred← citeshttps://doi.org/10.1016/j.ctrv.2020.102088openalex-snapshot
Immunotherapy in cervix cancer
inferred← citeshttps://doi.org/10.1016/j.humpath.2023.12.003openalex-snapshot
Systematic assessment of tumor necrosis at baseline in cervical cancer - An independent factor associated with poor outcome
inferred← citeshttps://doi.org/10.1016/j.ijgc.2025.101924openalex-snapshot
High human papillomavirus viral load and local immune dysregulation are associated with poor clinical outcomes in patients with cervical cancer
inferred← citeshttps://doi.org/10.1016/j.ijgc.2025.101930openalex-snapshot
Survival outcomes and safety of nimotuzumab combined with radiotherapy ± chemotherapy for locally advanced cervical cancer
inferred← citeshttps://doi.org/10.1016/j.ijrobp.2025.05.003openalex-snapshot
Atezolizumab and Stereotactic Body Radiation in Metastatic, Recurrent, or Persistent Cervical Cancer: Results From a Phase 2 Multi-Institutional Study
inferred← citeshttps://doi.org/10.1016/j.imlet.2026.107150openalex-snapshot
PD-L1 expression in cervical cancer tissue is strongly associated with the expression of CD73/TGF-β1, the percentage of CD8+/PD-1+ T cells and disease progression
inferred← citeshttps://doi.org/10.1016/j.intimp.2021.108484openalex-snapshot
PD-L1: Can it be a biomarker for the prognosis or a promising therapeutic target in cervical cancer?
inferred← citeshttps://doi.org/10.1016/j.intimp.2023.109774openalex-snapshot
Advances in the application of immune checkpoint inhibitors in gynecological tumors
inferred← citeshttps://doi.org/10.1016/j.jri.2022.103763openalex-snapshot
COVID-19 can lead to rapid progression of cervical intraepithelial neoplasia by dysregulating the immune system: A hypothesis
inferred← citeshttps://doi.org/10.1016/j.mjafi.2024.02.009openalex-snapshot
Assessment of programmed death ligand 1 (PD-L1) expression in cervical intraepithelial neoplasia and carcinoma cervix
inferred← citeshttps://doi.org/10.1016/j.neo.2026.101305openalex-snapshot
PIK3CA mutant cervical cancer is selectively suppressed by PI3Kα inhibition (Alpelisib/BYL-719 and Inavolisib/GDC-0077) and cooperates with HPV directed T cell therapy
inferred← citeshttps://doi.org/10.1016/j.omton.2024.200759openalex-snapshot
Targeting MELK improves PD-1 blockade efficiency in cervical cancer via enhancing antitumor immunity
inferred← citeshttps://doi.org/10.1016/j.prp.2019.152782openalex-snapshot
The immune checkpoints CTLA-4 and PD-L1 in carcinomas of the uterine cervix
inferred← citeshttps://doi.org/10.1016/j.prp.2020.152884openalex-snapshot
Cancer-associated fibroblasts promote cell growth by activating ERK5/PD-L1 signaling axis in colorectal cancer
inferred← citeshttps://doi.org/10.1016/j.semradonc.2019.08.009openalex-snapshot
Radiobiology: Foundation and New Insights in Modeling Brachytherapy Effects
inferred← citeshttps://doi.org/10.1016/j.tranon.2024.101884openalex-snapshot
Tissue contexture determines the pattern and density of tumor-infiltrating immune cells in HPV-associated squamous cell carcinomas of oropharynx and uterine cervix
inferred← citeshttps://doi.org/10.1016/j.tranon.2024.102265openalex-snapshot
Prognostic implications of immune classification based on PD-L1 expression and tumor-infiltrating lymphocytes in endocervical adenocarcinoma
inferred← citeshttps://doi.org/10.1016/j.tvr.2022.200238openalex-snapshot
Cervical cancer therapies: Current challenges and future perspectives
inferred← citeshttps://doi.org/10.1016/j.tvr.2025.200323openalex-snapshot
The immunological heterogeneity of squamous cell carcinoma and adenocarcinoma of the uterine cervix: a systematic review
inferred← citeshttps://doi.org/10.1016/j.ygyno.2019.04.013openalex-snapshot
Platinum single-agent vs. platinum-based doublet agent concurrent chemoradiotherapy for locally advanced cervical cancer: A meta-analysis of randomized controlled trials
inferred← citeshttps://doi.org/10.1016/j.ygyno.2020.06.506openalex-snapshot
PIK3CA mutation and CNV status and post-chemoradiotherapy survival in patients with cervical cancer
inferred← citeshttps://doi.org/10.1016/j.ygyno.2022.08.013openalex-snapshot
Comparison of global treatment guidelines for locally advanced cervical cancer to optimize best care practices: A systematic and scoping review
inferred← citeshttps://doi.org/10.1038/s41379-021-00979-4openalex-snapshot
Expression of B7 family checkpoint proteins in cervical cancer
inferred← citeshttps://doi.org/10.1038/s41416-020-01123-wopenalex-snapshot
Baseline immunity and impact of chemotherapy on immune microenvironment in cervical cancer
inferred← citeshttps://doi.org/10.1038/s41416-020-01184-xopenalex-snapshot
Infiltrating T-cell markers in cervical carcinogenesis: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1038/s41467-022-35133-4openalex-snapshot
A multicenter phase 2 trial of camrelizumab plus famitinib for women with recurrent or metastatic cervical squamous cell carcinoma
inferred← citeshttps://doi.org/10.1038/s41598-023-50452-2openalex-snapshot
Prognostic and immunological role of adaptor related protein complex 3 subunit mu2 in colon cancer
inferred← citeshttps://doi.org/10.1038/s41598-024-63595-7openalex-snapshot
PD-L1 expression in squamous cervical carcinomas of Mozambican women living with or without HIV
inferred← citeshttps://doi.org/10.1055/s-0043-1774709openalex-snapshot
Impact of Human Papillomavirus on Survival, Inflammation, and Immune Function in Patients with Cervical Cancer Undergoing Surgery
inferred← citeshttps://doi.org/10.1080/14712598.2019.1646721openalex-snapshot
Pembrolizumab for the treatment of cervical cancer
inferred← citeshttps://doi.org/10.1093/jjco/hyaa149openalex-snapshot
Association between cancer immunity and treatment results in uterine cervical cancer patients treated with radiotherapy
inferred← citeshttps://doi.org/10.1093/jrr/rrz106openalex-snapshot
Treatment outcomes of patients with adenocarcinoma of the uterine cervix after definitive radiotherapy and the prognostic impact of tumor-infiltrating CD8+ lymphocytes in pre-treatment biopsy specimens: a multi-institutional retrospective study
inferred← citeshttps://doi.org/10.1097/01.xej.0000534717.60403.bbopenalex-snapshot
Expression of immunomodulator programmed death ligand 1 and fork head box protein 3 in squamous cell carcinoma of cervix
inferred← citeshttps://doi.org/10.1097/gco.0000000000000755openalex-snapshot
Precision medicine for cervical cancer
inferred← citeshttps://doi.org/10.1097/pas.0000000000001633openalex-snapshot
PD-L1 Expression in Endocervical Adenocarcinoma
inferred← citeshttps://doi.org/10.1097/pas.0000000000001800openalex-snapshot
The Prognostic Values of HPV Genotypes and Tumor PD-L1 Expression in Patients With HPV-associated Endocervical Adenocarcinoma
inferred← citeshttps://doi.org/10.1097/pgp.0000000000000755openalex-snapshot
The Role of Predictive Biomarkers in Endocervical Adenocarcinoma: Recommendations From the International Society of Gynecological Pathologists
inferred← citeshttps://doi.org/10.1097/pgp.0000000000000890openalex-snapshot
Programmed Death Ligand 1 (PD-L1) Expression and CD8+ Tumor-infiltrating Lymphocyte-based Tumor Immune Microenvironment Classification in Gynecologic Carcinosarcoma: Prognostic Impact and Implications for Therapy
inferred← citeshttps://doi.org/10.1097/pgp.0000000000000975openalex-snapshot
Programmed Death Ligand-1 (PD-L1) Expression in Cervical Squamous Cell Carcinoma: Does it Correlate With Outcomes?
inferred← citeshttps://doi.org/10.1097/pgp.0000000000000978openalex-snapshot
Prevalence and Prognostic Significance of PIK3CA Mutation and CNV Status and Phosphorylated AKT Expression in Patients With Cervical Cancer Treated With Primary Surgery
inferred← citeshttps://doi.org/10.1111/his.14552openalex-snapshot
Programmed death‐ligand 1 expression in human papillomavirus‐independent cervical adenocarcinoma and its prognostic significance
inferred← citeshttps://doi.org/10.1136/ijgc-2019-000556openalex-snapshot
Distinctive clinicopathologic characteristics and prognosis for different histologic subtypes of early cervical cancer
inferred← citeshttps://doi.org/10.1136/ijgc-2019-001135openalex-snapshot
CALLA: Efficacy and safety of concurrent and adjuvant durvalumab with chemoradiotherapy versus chemoradiotherapy alone in women with locally advanced cervical cancer: a phase III, randomized, double-blind, multicenter study
inferred← citeshttps://doi.org/10.1136/ijgc-2021-002492openalex-snapshot
Advances in immunotherapy for cervical cancer: recent developments and future directions
inferred← citeshttps://doi.org/10.1136/ijgc-2021-002529openalex-snapshot
Combined modality including novel sensitizers in gynecological cancers
inferred← citeshttps://doi.org/10.1136/jitc-2020-000612openalex-snapshot
Immunomodulation to enhance the efficacy of an HPV therapeutic vaccine
inferred← citeshttps://doi.org/10.1136/jitc-2022-006624openalex-snapshot
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gynecologic cancer
inferred← citeshttps://doi.org/10.1155/2020/1283632openalex-snapshot
Expression and Significance of Immune Checkpoints in Clear Cell Carcinoma of the Uterine Cervix
inferred← citeshttps://doi.org/10.1155/2020/8164365openalex-snapshot
Uncovering PD‐L1 and CD8+ TILS Expression and Clinical Implication in Cervical Squamous Cell Carcinoma
inferred← citeshttps://doi.org/10.1177/10732748251336415openalex-snapshot
Advances and Challenges in Cervical Cancer: From Molecular Mechanisms and Global Epidemiology to Innovative Therapies and Prevention Strategies
inferred← citeshttps://doi.org/10.1177/15330338231208846openalex-snapshot
Research Progress of Immuno-Inhibitory Receptors in Gynecological Cervical Cancer
inferred← citeshttps://doi.org/10.1177/17588359231163836openalex-snapshot
Advances in immunotherapy for cervical cancer
inferred← citeshttps://doi.org/10.1177/17588359251361880openalex-snapshot
Clinical and pathological analyses of gastric-type cervical adenocarcinoma and its prognostic relevance
inferred← citeshttps://doi.org/10.1186/s12885-022-09866-wopenalex-snapshot
Toripalimab combined with concurrent platinum-based Chemoradiotherapy in patients with locally advanced cervical Cancer: an open-label, single-arm, phase II trial
inferred← citeshttps://doi.org/10.1186/s12885-025-13901-xopenalex-snapshot
Single-cell transcriptomic analysis reveals CD8 + T cell heterogeneity and identifies a prognostic signature in cervical cancer
inferred← citeshttps://doi.org/10.1186/s12920-022-01376-9openalex-snapshot
Genomic landscape, immune characteristics and prognostic mutation signature of cervical cancer in China
inferred← citeshttps://doi.org/10.1186/s12935-019-0861-7openalex-snapshot
Elevated PD-L1 expression predicts poor survival outcomes in patients with cervical cancer
inferred← citeshttps://doi.org/10.1186/s12967-021-02898-zopenalex-snapshot
Automated tumor proportion scoring for PD-L1 expression based on multistage ensemble strategy in non-small cell lung cancer
inferred← citeshttps://doi.org/10.1186/s13048-019-0512-6openalex-snapshot
Prognostic effect of programmed death-ligand 1 (PD-L1) in ovarian cancer: a systematic review, meta-analysis and bioinformatics study
inferred← citeshttps://doi.org/10.1186/s40425-018-0326-xopenalex-snapshot
Measuring multiple parameters of CD8+ tumor-infiltrating lymphocytes in human cancers by image analysis
inferred← citeshttps://doi.org/10.1200/edbk_438582openalex-snapshot
Updates in the Use of Targeted Therapies for Gynecologic Cancers
inferred← citeshttps://doi.org/10.1200/jco.20.01920openalex-snapshot
Camrelizumab Plus Apatinib in Patients With Advanced Cervical Cancer (CLAP): A Multicenter, Open-Label, Single-Arm, Phase II Trial
inferred← citeshttps://doi.org/10.1200/jco.21.02091openalex-snapshot
Efficacy and Safety of Sintilimab Plus Anlotinib for PD-L1–Positive Recurrent or Metastatic Cervical Cancer: A Multicenter, Single-Arm, Prospective Phase II Trial
inferred← citeshttps://doi.org/10.1371/journal.pone.0263615openalex-snapshot
Programme death ligand 1 expressions as a surrogate for determining immunotherapy in cervical carcinoma patients
inferred← citeshttps://doi.org/10.1371/journal.pone.0350571openalex-snapshot
Efficacy and safety of immune checkpoint inhibitors combined with TKIs for recurrent or metastatic cervical cancer with PIK3CA mutation
inferred← citeshttps://doi.org/10.14670/hh-18-796openalex-snapshot
Tissue microarray validation in cervical carcinoma studies. A methodological approach.
inferred← citeshttps://doi.org/10.15761/icst.1000272openalex-snapshot
PD-1/PD-L1 immune checkpoint inhibitors in advanced cervical cancer
inferred← citeshttps://doi.org/10.1590/1414-431x2026e15368openalex-snapshot
Bulk and single cell RNA sequencing data reveal lactylation-related gene signatures for prognosis and immunity in cervical cancer
inferred← citeshttps://doi.org/10.1615/critrevimmunol.2025061164openalex-snapshot
Single-Cell Sequencing Combined with RNA Sequencing Reveals the Role of Natural Killer Cells in Prognosis and Immunotherapy Response in Cervical Squamous Cell Carcinoma
inferred← citeshttps://doi.org/10.17116/patol2023850515openalex-snapshot
Predictive markers of immunotherapy in cervical cancer
inferred← citeshttps://doi.org/10.17650/1994-4098-2021-17-2-104-111openalex-snapshot
Modern possibilities of using immunotherapy in the treatment of cervical cancer
inferred← citeshttps://doi.org/10.18053/jctres.09.202304.23-00067openalex-snapshot
PD-L1 expression and prognosis in definitive radiotherapy patients with neuroendocrine cervical carcinoma
inferred← citeshttps://doi.org/10.18410/jebmh/2020/265openalex-snapshot
Immunohistochemical Expression of PDL1 in Pre-Malignant and Malignant Lesions of Cervix
inferred← citeshttps://doi.org/10.20517/cdr.2023.120openalex-snapshot
The evolving role of immune checkpoint inhibitors in cervical and endometrial cancer
inferred← citeshttps://doi.org/10.21037/tlcr.2020.03.34openalex-snapshot
The prevalence and prognostic significance of estrogen receptor beta expression in non-small cell lung cancer
inferred← citeshttps://doi.org/10.21147/j.issn.1000-9604.2018.02.04openalex-snapshot
Systemic therapy for cervical carcinoma – current status
inferred← citeshttps://doi.org/10.21203/rs.3.rs-1324764/v1openalex-snapshot
Genomic landscape, immune characteristics and a prognostic mutation signature of cervical cancer in China
inferred← citeshttps://doi.org/10.21203/rs.3.rs-640056/v1openalex-snapshot
Constructing A Novel Signature Based on Immune-Related Lncrna to Improve Prognosis Prediction of Cervical Squamous Cell Carcinoma Patients
inferred← citeshttps://doi.org/10.21203/rs.3.rs-94429/v1openalex-snapshot
A riskscore-based nomogram for the prediction of overall survival in cervical squamous cell carcinoma
inferred← citeshttps://doi.org/10.2144/fsoa-2020-0063openalex-snapshot
Association of PD-L1 Expression with Prognosis Among Patients with Ten Uncommon Advanced Cancers
inferred← citeshttps://doi.org/10.2147/cmar.s194597openalex-snapshot
Expression of PD-L1 in cervical carcinoma and its impact on survival associated with T-cell infiltration and FoxP3 expression
inferred← citeshttps://doi.org/10.2147/cmar.s238643openalex-snapshot
Ultrasound-Mediated Co-Delivery of miR-34a and sPD-1 Complexed with Microbubbles for Synergistic Cancer Therapy
inferred← citeshttps://doi.org/10.2147/ott.s226465openalex-snapshot
miR-140-3p Suppresses Cell Growth And Induces Apoptosis In Colorectal Cancer By Targeting PD-L1
inferred← citeshttps://doi.org/10.2147/ott.s282530openalex-snapshot
Emerging Targets of Immunotherapy in Gynecologic Cancer
inferred← citeshttps://doi.org/10.2147/ott.s318082openalex-snapshot
Expression of B7-H3 Correlates with PD-L1 and Poor Prognosis in Patients with Cervical Cancer
inferred← citeshttps://doi.org/10.21518/2079-701x-2020-9-121-126openalex-snapshot
Molecular-guided therapy for disseminated cervical cancer: present and future
inferred← citeshttps://doi.org/10.21518/2079-701x-2021-9-76-86openalex-snapshot
The role of immunotherapy in the management of metastatic/recurrent female reproductive system neoplasms
inferred← citeshttps://doi.org/10.21518/ms2024-245openalex-snapshot
The evolution of treatment for advanced cervical cancer: from cisplatin monotherapy to immuno-oncology combinations
inferred← citeshttps://doi.org/10.2174/0109298673337745241123054840openalex-snapshot
Surgical Advancements, Immunotherapy, Targeted and Conventional Therapies, Biopsy, Colposcopy, and Pap Smear Integration in the Management of Cervical Cancer
inferred← citeshttps://doi.org/10.2174/0929867327666200128105459openalex-snapshot
The Roles of Programmed Cell Death Ligand-1/ Programmed Cell Death-1 (PD-L1/PD-1) in HPV-induced Cervical Cancer and Potential for their Use in Blockade Therapy
inferred← citeshttps://doi.org/10.21873/anticanres.11926openalex-snapshot
Identifying Rational Candidates for Immunotherapy Targeting PD-1/PD-L1 in Cervical Cancer
inferred← citeshttps://doi.org/10.21873/anticanres.16368openalex-snapshot
CD8-positive Tumor-infiltrating Lymphocytes and Prognosis in Radiotherapy for Uterine Cervical Squamous Cell Carcinoma
inferred← citeshttps://doi.org/10.21873/invivo.12379openalex-snapshot
Response to Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer: The Role of Immune-related Factors
inferred← citeshttps://doi.org/10.2217/nnm-2019-0397openalex-snapshot
Anti-PD-L1-Modified and ATRA-Loaded Nanoparticles for Immuno-Treatment of Oral Dysplasia and Oral Squamous Cell Carcinoma
inferred← citeshttps://doi.org/10.24875/ric.20000060openalex-snapshot
Immunotherapy Treatment Against Cervical Cancer
inferred← citeshttps://doi.org/10.31917/2104305openalex-snapshot
Immune checkpoint inhibitors in the treatment of cervical cancer: literature review
inferred← citeshttps://doi.org/10.33667/2078-5631-2023-36-42-50openalex-snapshot
Vaccination and modern therapy of cervical cancer
inferred← citeshttps://doi.org/10.3389/fcell.2021.677831openalex-snapshot
Identification of an Metabolic Related Risk Signature Predicts Prognosis in Cervical Cancer and Correlates With Immune Infiltration
inferred← citeshttps://doi.org/10.3389/fimmu.2020.587460openalex-snapshot
Soluble PD-1: Predictive, Prognostic, and Therapeutic Value for Cancer Immunotherapy
inferred← citeshttps://doi.org/10.3389/fimmu.2020.596825openalex-snapshot
PD-L1 and PD-L2 Expression in Cervical Cancer: Regulation and Biomarker Potential
inferred← citeshttps://doi.org/10.3389/fimmu.2023.1113369openalex-snapshot
Tislelizumab for cervical cancer: A retrospective study and analysis of correlative blood biomarkers
inferred← citeshttps://doi.org/10.3389/fimmu.2024.1357601openalex-snapshot
Case report: Giant lymph node metastases: a new opportunity for cancer radioimmunotherapy?
inferred← citeshttps://doi.org/10.3389/fimmu.2026.1840435openalex-snapshot
HPV viral load predicts immune exhaustion and prognosis in cervical neoplasia
inferred← citeshttps://doi.org/10.3389/fimmu.2026.1850891openalex-snapshot
Prognostic value of an integrated immune-inflammatory phenotype in surgically treated cervical cancer: survival modeling and immunohistochemical validation
inferred← citeshttps://doi.org/10.3389/fmed.2021.755657openalex-snapshot
Prognostic Value of Tumor Mutational Burden Related to Immune Infiltration in Cervical Squamous Cell Carcinoma
inferred← citeshttps://doi.org/10.3389/fonc.2020.00914openalex-snapshot
High-Risk HPV Oncoproteins and PD-1/PD-L1 Interplay in Human Cervical Cancer: Recent Evidence and Future Directions
inferred← citeshttps://doi.org/10.3389/fonc.2020.572203openalex-snapshot
Predictive Values of Programmed Cell Death-Ligand 1 Expression for Prognosis, Clinicopathological Factors, and Response to Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Inhibitors in Patients With Gynecological Cancers: A Meta-Analysis
inferred← citeshttps://doi.org/10.3389/fonc.2021.752453openalex-snapshot
PD-L1, Mismatch Repair Protein, and NTRK Immunohistochemical Expression in Cervical Small Cell Neuroendocrine Carcinoma
inferred← citeshttps://doi.org/10.3389/fonc.2022.858164openalex-snapshot
PD-1/PD-L1 Correlates With the Efficacy of the Treatment of Concurrent Chemoradiotherapy in Cervical Cancer
inferred← citeshttps://doi.org/10.3389/fonc.2022.996495openalex-snapshot
Immune checkpoint inhibitors in advanced and recurrent/metastatic cervical cancer
inferred← citeshttps://doi.org/10.3389/fonc.2024.1375035openalex-snapshot
Case report: A case of recurrent cervical cancer with bronchial and esophageal metastases presenting with hemoptysis and dysphagia
inferred← citeshttps://doi.org/10.3389/fonc.2024.1392639openalex-snapshot
Advanced, recurrent, and persistent cervical cancer management: in the era of immunotherapy
inferred← citeshttps://doi.org/10.3389/fonc.2024.1429176openalex-snapshot
An early combination of concurrent chemoradiotherapy with immune checkpoint inhibitors for cervical cancer is superior to a late combination: a propensity-score matching analysis
inferred← citeshttps://doi.org/10.3389/fonc.2024.1488730openalex-snapshot
The potential role of HPV oncoproteins in the PD-L1/PD-1 pathway in cervical cancer: new perspectives on cervical cancer immunotherapy
inferred← citeshttps://doi.org/10.3389/fphar.2019.00065openalex-snapshot
PD-1/PD-L1 Inhibitors in Cervical Cancer
inferred← citeshttps://doi.org/10.3389/fphar.2022.843905openalex-snapshot
Efficacy and Safety of Apatinib for the Treatment of Advanced or Recurrent Cervical Cancer: A Single-Arm Meta-Analysis Among Chinese Patients
inferred← citeshttps://doi.org/10.3390/cancers11040541openalex-snapshot
Low CD8+ T Cell Infiltration and High PD-L1 Expression Are Associated with Level of CD44+/CD133+ Cancer Stem Cells and Predict an Unfavorable Prognosis in Pancreatic Cancer
inferred← citeshttps://doi.org/10.3390/cancers13092089openalex-snapshot
Role of Immune Checkpoint Inhibitors in Cervical Cancer: From Preclinical to Clinical Data
inferred← citeshttps://doi.org/10.3390/cancers13225748openalex-snapshot
Molecular Markers to Predict Prognosis and Treatment Response in Uterine Cervical Cancer
inferred← citeshttps://doi.org/10.3390/cancers14235955openalex-snapshot
Beyond Platinum, ICIs in Metastatic Cervical Cancer: A Systematic Review
inferred← citeshttps://doi.org/10.3390/cancers15153849openalex-snapshot
Tumor Immune Microenvironment in Gynecologic Cancers
inferred← citeshttps://doi.org/10.3390/cells10051006openalex-snapshot
Tumour Hypoxia-Mediated Immunosuppression: Mechanisms and Therapeutic Approaches to Improve Cancer Immunotherapy
inferred← citeshttps://doi.org/10.3390/healthcare7030108openalex-snapshot
Immunotherapy for Uterine Cervical Cancer
inferred← citeshttps://doi.org/10.3390/ijms21072335openalex-snapshot
Immunotherapy for Uterine Cervical Cancer Using Checkpoint Inhibitors: Future Directions
inferred← citeshttps://doi.org/10.3390/ijms22041807openalex-snapshot
Targeting the PD-1 Axis with Pembrolizumab for Recurrent or Metastatic Cancer of the Uterine Cervix: A Brief Update
inferred← citeshttps://doi.org/10.3390/ijms23073559openalex-snapshot
Immunotherapy for Cervical Cancer: Are We Ready for Prime Time?
inferred← citeshttps://doi.org/10.3390/jcm11092277openalex-snapshot
A Review of the Effects of Cervical Cancer Standard Treatment on Immune Parameters in Peripheral Blood, Tumor Draining Lymph Nodes, and Local Tumor Microenvironment
inferred← citeshttps://doi.org/10.3390/jcm11133830openalex-snapshot
Moesin Serves as Scaffold Protein for PD-L1 in Human Uterine Cervical Squamous Carcinoma Cells
inferred← citeshttps://doi.org/10.3390/medicina61112007openalex-snapshot
Interplay Between Immune Microenvironment CD8+ Tumor-Infiltrating Lymphocytes and PDL-1 Expression as Prognostic Markers in Invasive Cervical Squamous Cell Carcinoma
inferred← citeshttps://doi.org/10.3390/molecules26185648openalex-snapshot
Ezrin Modulates the Cell Surface Expression of Programmed Cell Death Ligand-1 in Human Cervical Adenocarcinoma Cells
inferred← citeshttps://doi.org/10.3390/ph17030397openalex-snapshot
Adenosine Increases the Immunosuppressive Capacity of Cervical Cancer Cells by Increasing PD-L1 Expression and TGF-β Production through Its Interaction with A2AR/A2BR
inferred← citeshttps://doi.org/10.34297/ajbsr.2023.18.002423openalex-snapshot
Novel Biomarkers are Emerging in Cervical Adenocarcinoma: A Short Review
inferred← citeshttps://doi.org/10.37349/emed.2024.00226openalex-snapshot
The future of cervical cancer prevention: advances in research and technology
inferred← citeshttps://doi.org/10.3802/jgo.2024.35.e105openalex-snapshot
Prevalence and prognostic value of PD-L1 expression and tumor mutational burden in persistent, recurrent, or metastatic cervical cancer
inferred← citeshttps://doi.org/10.3892/etm.2021.9615openalex-snapshot
Effects of transcutaneous electrical acupoint stimulation on perioperative immune function and postoperative analgesia in patients undergoing radical mastectomy: A randomized controlled trial
inferred← citeshttps://doi.org/10.3892/ol.2021.12707openalex-snapshot
Analysis of radiotherapy‑induced alteration of CD8+ T cells and PD‑L1 expression in patients with uterine cervical squamous cell carcinoma
inferred← citeshttps://doi.org/10.3892/ol.2025.14963openalex-snapshot
Prognostic value of HER2 expression in cervical adenocarcinoma: A retrospective cohort study
inferred← citeshttps://doi.org/10.3892/or.2023.8551openalex-snapshot
TFAP2A promotes cervical cancer via a positive feedback pathway with PD‑L1
inferred← citeshttps://doi.org/10.4103/crst.crst_98_22openalex-snapshot
Programmed death ligand (PD-L1) expression in invasive squamous cell carcinoma of the uterine cervix: A cross-sectional observational study
inferred← citeshttps://doi.org/10.4103/ijpm.ijpm_572_24openalex-snapshot
Clinicopathological association of programmed death-ligand 1 (PD-L1) expression in uterine cervical carcinomas: A cross-sectional observational study
inferred← citeshttps://doi.org/10.4103/jcsr.jcsr_24_24openalex-snapshot
Programmed cell death-ligand 1 expression in correlation with human papillomavirus status in cervical cancer: A 1-year retrospective study
inferred← citeshttps://doi.org/10.52420/2071-5943-2021-20-2-36-42openalex-snapshot
Features of the lymphocytic microenvironment in metastatic uveal melanoma
inferred← citeshttps://doi.org/10.52420/2071-5943-2021-20-4-78-84openalex-snapshot
Antitumor effect on immune control points (PD-1/PD-L1) in malignant neoplasms
inferred← citeshttps://doi.org/10.53555/ajbr.v27i4s.8149openalex-snapshot
Biomarkers For Screening, Diagnosis and Treatment Stratification of Cervical Cancer: A Review
inferred← citeshttps://doi.org/10.5468/ogs.2020.63.3.346openalex-snapshot
Prognostic value of programmed cell death ligand-1 expression in ovarian cancer: an updated meta-analysis
inferred← citeshttps://doi.org/10.5582/bst.2019.01003openalex-snapshot
Programmed death ligand-1, tumor infiltrating lymphocytes and HLA expression in Chinese extrahepatic cholangiocarcinoma patients: Possible immunotherapy implications
inferred← citeshttps://doi.org/10.5603/gp.a2022.0071openalex-snapshot
Predictive values of PD‑L1 expression for survival outcomes in patients with cervical cancer: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.5935/2526-8732.20220313openalex-snapshot
Prevalence and prognostic value of the programmed cell death-ligand 1 (PD-L1) expression among tumor samples from cervical cancer patients
inferred← citeshttps://doi.org/10.6084/m9.figshare.14746587openalex-snapshot
Additional file 1 of Automated tumor proportion scoring for PD-L1 expression based on multistage ensemble strategy in non-small cell lung cancer
inferred← citeshttps://doi.org/10.62051/s99byb48openalex-snapshot
Current Status Of Immunotherapy For Cervical Cancer
inferred← citeshttps://doi.org/10.64898/2026.01.21.26344562openalex-snapshot
A Three-subtype Molecular model of Cervical Cancer: Multiple PI3K Pathway inhibitors suppress growth and cooperate with HPV-directed immunotherapy
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.